For the 12th consecutive year, OMRF hosted a Halloween event for more than 70 trick-or-treaters from Positive Tomorrows.
News
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
Fear itself: Unmasking the fight-or-flight response
So, what exactly happens inside your body when things go bump in the night?
New OMRF grant will focus on autoimmune condition
The project will focus on comparing certain immune cells in patients with Sjögren’s to those of healthy controls.
241 events raise $695,000 for OMRF research
Seventh annual concert and golf tournament benefit research
OMRF awarded two new grants to study lupus genes
Two grants will enable OMRF scientists to examine genes thought to play a role in lupus.
